Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +48.81%
#3 Black Phoenix Black Phoenix +34.68%
#4 Velvet Velvet +29.04%
#5 Cross Cross +22.45%
#6 Akedo Akedo +17.41%
#7 DoubleZero DoubleZero +14.34%
#8 Cap Cap +11.68%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.22%
#10 HOME HOME +10.23%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Classifica tra le azioni #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Prezzo delle azioni
$0.0202
Ultima sincronizzazione: 2024-11-19
Capitalizzazione di mercato
$44.67K
Variazione (1 giorno)
-0.49%
Variazione (1 anno)
0.00%
Paese
IL
Scambia Notable Labs, Ltd. (NTBL)

Categoria

Healthcare
Ricavi di Notable Labs, Ltd. (NTBL)
Ricavi nel Jun 2024 TTM: $3.00K
Secondo gli ultimi rapporti finanziari di Notable Labs, Ltd., i ricavi attuali dell'azienda (TTM) sono pari a $3.00K. Nel 2022, l'azienda ha registrato ricavi di $8.00K una diminuzione rispetto a i ricavi dell'anno 2021, che erano pari a $285.00K. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Notable Labs, Ltd. da 2015 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $3.00K -99.03%
2023 $310.00K 3,775.00%
2022 $8.00K -97.19%
2021 $285.00K -69.09%
2020 $922.00K 64.06%
2019 $562.00K -3.93%
2018 $585.00K -95.78%
2017 $13.86M 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 420,809,900.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 200,709,476.97%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 337,026,123.20%
BE